Kezar Life Sciences

green light shining in night
Biotech

Kezar sees hepatitis hold lifted, mulls restarting lupus program

The FDA lifted a clinical hold placed on Kezar’s zetomipzomib, leading the biotech to speculate on whether to reignite another program still on hold.
James Waldron Jul 16, 2025 8:47am
FDA stop sign

FDA hits Kezar's zetomipzomib with 2nd clinical hold in 2 months

Nov 13, 2024 5:22am
Withdraw cancel rip up application

Kezar rejects Concentra buyout that 'undervalues' the biotech

Oct 17, 2024 9:10am
Pac man eat MA deal buy sell merger

With Kezar in lupus limbo, Concentra spies potential acquisition

Oct 9, 2024 7:10am
FDA stop sign

FDA places Kezar lupus trial in hold following 4 patient deaths

Oct 7, 2024 5:50am
red light stop light street traffic signal

Kezar suspends key lupus study after 4 deaths

Sep 30, 2024 11:23am